Does METHYLPREDNISOLONE Cause Immune-mediated hepatitis? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Immune-mediated hepatitis have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.1% of all adverse event reports for METHYLPREDNISOLONE.
30
Reports of Immune-mediated hepatitis with METHYLPREDNISOLONE
0.1%
of all METHYLPREDNISOLONE reports
10
Deaths
13
Hospitalizations
How Dangerous Is Immune-mediated hepatitis From METHYLPREDNISOLONE?
Of the 30 reports, 10 (33.3%) resulted in death, 13 (43.3%) required hospitalization, and 5 (16.7%) were considered life-threatening.
Is Immune-mediated hepatitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Immune-mediated hepatitis?
NIVOLUMAB (640)
PEMBROLIZUMAB (549)
IPILIMUMAB (443)
CARBOPLATIN (213)
PACLITAXEL (167)
ATEZOLIZUMAB (142)
BEVACIZUMAB (108)
DURVALUMAB (90)
LENVATINIB (86)
PEMETREXED (86)
Which METHYLPREDNISOLONE Alternatives Have Lower Immune-mediated hepatitis Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE